Anzeige
Mehr »
Freitag, 18.09.2026 - Börsentäglich über 12.000 News
Wie Canaccord aus jedem Dollar zwei Dollar Wert modelliert
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
95 Leser
Artikel bewerten:
(0)

Enzymes Market worth $23.74 billion by 2031- Exclusive Report by MarketsandMarkets

DELRAY BEACH, Fla., Sept. 18, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Enzymes Market is estimated to grow from USD 16.15 billion in 2026 to USD 23.74 billion by 2031, at a CAGR of 8.0% from 2026 to 2031.

Enzymes Market Size & Forecast

  • Market Size Available for Years: 2022-2031
  • 2026 Market Size: USD 16.15 billion
  • 2031 Projected Market Size: USD 23.74 billion
  • CAGR (2026-2031): 8.0%

Enzymes Market Trends & Insights:

  • The demand for enzymes is expected to grow steadily, supported by increasing adoption across food & beverages, animal feed, biofuels, detergents, textiles & leather, pulp & paper, wastewater treatment, pharmaceuticals, and biotechnology. Enzymes are widely used to improve process efficiency, product quality, and yield while reducing energy, chemical, and resource consumption. Growing demand for processed foods, rising biofuel production, expansion of industrial biotechnology, and increasing focus on sustainable manufacturing are expected to further support market growth.
  • The South America is projected to register the highest CAGR of 9.1% during the forecast period.
  • The wastewater treatment segment is expected to be the fastest growing, registering a CAGR of 9.2% during the forecast period.
  • The plant segment is expected to register the highest CAGR of 8.4% during the forecast period.
  • Proteases are expected to be the fastest-growing enzyme type, while Carbohydrases are expected to account for the largest market share during the forecast period.
  • Industrial enzymes are expected to account for the largest share of the enzymes market by 2031.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46202020

The demand for enzymes is poised to grow steadily, supported by increasing adoption across food & beverages, animal feed, biofuels, detergents, textiles & leather, pulp & paper, wastewater treatment, pharmaceuticals, and biotechnology. Enzymes are widely used to improve process efficiency, product quality, and yield while reducing energy, chemical, and resource consumption. Growing demand for processed foods, rising biofuel production, expansion of industrial biotechnology, and increasing focus on sustainable manufacturing are expected to further support market growth.

Enzymes are available in a wide range of types and sources, including carbohydrases, proteases, lipases, polymerases & nucleases, and other enzymes, derived from microorganisms, plants, and animals. Increasing use of engineered and application-specific enzymes, advances in fermentation and enzyme engineering technologies, and growing adoption of enzyme-based solutions in emerging applications such as wastewater treatment are expected to create further opportunities for market participants.

By industrial enzyme application, food & beverages is expected to account for the largest market share during the forecast period.

Food & beverages is expected to remain the leading application for industrial enzymes, supported by their widespread use in bakery, dairy, brewing, starch processing, and other food manufacturing processes. Increasing demand for improved processing efficiency, product consistency, yield, and quality continues to support the extensive use of enzymes across the food & beverage industry.

By product type, industrial enzymes are expected to account for the largest market share during the forecast period.

Industrial enzymes are expected to maintain their dominant position due to their broad application across food & beverages, animal feed, detergents, biofuels, textiles, pulp & paper, and wastewater treatment. Their established use in large-scale industrial processes and ability to improve process efficiency, productivity, and resource utilization support their continued market presence.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46202020

By region, Asia Pacific is expected to account for the second-largest market share during the forecast period.

The Asia Pacific region will account for the second-largest share of the enzymes market during the forecast period. Growth in the Asia Pacific market is supported by expanding food & beverage processing, animal feed production, biofuel manufacturing, and industrial biotechnology activities. Rising industrialization, increasing adoption of advanced processing technologies, and growing demand for efficient and sustainable production solutions are contributing to enzyme consumption across the region. China, India, Japan, and other emerging economies are expected to provide significant opportunities as manufacturers increasingly adopt enzymes to improve productivity, product quality, and resource efficiency.

Top Companies in the Enzymes Market

The report profiles key players such as BASF SE (Germany), International Flavors & Fragrances Inc. (US), dsm-firmenich (Switzerland), Associated British Foods plc (UK), Novonesis Group (Denmark), and Kerry Group plc (Ireland), among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=46202020

Investment and Funding Context

Alltech is a global animal nutrition and biosolutions company with a portfolio spanning animal nutrition, health, and biological solutions for soil and plants. The company has raised an undisclosed amount in funding, with its latest reported funding round being a grant (prize money) in January 2025 from the US Department of Agriculture. Alltech's investment and innovation activities support the development and commercialization of biological and enzyme-based solutions for animal nutrition and sustainable agriculture.

Revenue Shift Context

The global enzymes market is shifting toward higher-performance, application-specific, and sustainable enzyme solutions, supported by growing demand across food & beverages, animal feed, biofuels, detergents, pharmaceuticals, and industrial applications. Market spending is estimated to increase from USD 16.15 billion in 2026 to USD 23.74 billion by 2031, at a CAGR of 8.0%. This shift reflects increasing adoption of enzymes that improve process efficiency, product quality, yield, and resource utilization, while supporting lower energy and chemical consumption.

Mergers and Acquisitions

Key players are pursuing acquisitions to strengthen their enzyme portfolios, expand customer reach, and enhance their positions across high-growth applications. In February 2025, Novonesis Group agreed to acquire dsm-firmenich's share of the Feed Enzyme Alliance for EUR 1.5 billion (USD 1.69 billion) in cash. The transaction enabled Novonesis to take over the Alliance's sales and distribution activities, integrate them with its existing enzyme innovation and production capabilities, and strengthen its position across the animal biosolutions value chain.

In December 2023, Kerry Group announced an agreement to acquire the global lactase enzymes business of Chr. Hansen and Novozymes, referred to here as Novonesis Group, for EUR 150 million (USD 162.3 million). The acquisition added the NOLA lactase portfolio to Kerry's biotechnology capabilities and strengthened its position in enzyme solutions for lactose-free and sugar-reduced dairy products. The business had approximately EUR 40 million in attributable revenue in 2022 and sales across more than 50 countries.

ENZYMES MARKET: MERGERS AND ACQUISITIONS, JANUARY 2023-AUGUST 2026

Month & Year

Deal Type

Company 1

Company 2

Description

Feb-25

Acquisition

Novonesis Group (Denmark)

dsm-firmenich (Switzerland)

Novonesis Group agreed to acquire dsm-firmenich's share of the Feed Enzyme Alliance for EUR 1.5 billion (USD 1.69 billion), taking over its sales and distribution activities and strengthening its integrated feed enzyme business.

Dec-23

Acquisition

Kerry Group plc (Ireland)

Novonesis Group (Denmark)

Kerry agreed to acquire the global lactase enzymes business for EUR 150 million (USD 162.3 million), adding NOLA lactase technology and strengthening its enzyme solutions for lactose-free and sugar-reduced dairy products.

Company Revenue Share Details

The enzymes market is moderately fragmented, with leading companies including BASF SE (Germany), International Flavors & Fragrances Inc. (US), dsm-firmenich (Switzerland), Novozymes Group (Denmark), and Kerry Group plc (Ireland). Together, these top five companies are estimated to account for approximately 46% of the market. They compete by offering broad product portfolios, advanced enzymes, extensive global distribution networks, strong regulatory capabilities, and tailored solutions for industrial and specialized needs.

Browse Adjacent Reports @ Food and Beverage Market Research Reports & Consulting

Related Reports:

Food Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases, & Nucleases), Application (Food & Beverages), Source (Microorganisms, Animals, & Plants), Formulation, Functional Role, and Region - Global Forecast to 2030

Industrial Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases, and Nucleases), Application (Food & Beverages, Bioethanol, Feed, Detergents, Wastewater, Soil, and Oil Treatment), Source, Formulation, and Region - Global Forecast to 2030

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/enzyme-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/enzyme.asp

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/enzymes-market-worth-23-74-billion-by-2031-exclusive-report-by-marketsandmarkets-302883007.html

© 2026 PR Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.